Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
07/2003
07/09/2003CN1113873C Novel optionally substitued phenylimidazolidines, intermediates and process for prepn. thereof, use as druge and pharmaceutical composition contg. same
07/08/2003US6589976 Particularly effective wood preservation is achieved by impregnation processes on a large industrial scale, for example vacuum, a double vacuum or pressure processes.
07/08/2003US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
07/08/2003US6589971 A method of treatment of a neoplastic disease in a patient in need of said treatment by administering a therapeutically effective amount of a compound of the formula: bind to specific sequences in the minor groove of duplex DNA, and to
07/08/2003US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful
07/08/2003US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production
07/08/2003CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists
07/03/2003WO2003053938A1 Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053344A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
07/03/2003US20030125550 1-aryl or heteroaryl substituted benzimidazole derivatives useful for treatment of diseases that are associated with microglia activation, such as inflammatory, allergic infectious or autoimmune diseases
07/03/2003US20030125494 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/02/2003EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
07/02/2003EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/02/2003EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/02/2003EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/01/2003US6586435 Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
06/2003
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051822A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003WO2003051821A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003WO2003051277A2 Novel compounds
06/26/2003US20030119868 Gyrase inhibitors and uses thereof
06/26/2003US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections
06/26/2003CA2470491A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003CA2469302A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003CN1426406A Process for producing optically active sulfoxide devivative'
06/25/2003CN1426401A Novel, slow-acting betamimetics, method for their production and their use as medicaments
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1425654A Process for preparing 2-alkoxybenzimidazole compound
06/24/2003US6583169 N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2179015C Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114457 2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/12/2003WO2003047626A1 Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
06/12/2003US20030109715 3,4-Dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030106169 Chromatic direct dyes of 2-azo benzimidazole, benzothiazole or benzoxaozle derivatives
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP0821586B1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/05/2003WO2003045929A1 Bicyclic derivative, process for producing the same, and use
06/05/2003WO2003004464A3 Heterocyclic amide derivatives and the use thereof as pesticides
06/05/2003US20030105137 Tryptase inhibitor; antiinflamamtory agents, antiallergens
06/05/2003US20030105062 Anti-bacterial agents based upon oxoanion binding
06/05/2003US20030105048 For in vitro, in vivo or ex vivo transfer of nucleic acids into cells or for the visualization of the nucleic acids administered, by fluorescence
06/05/2003US20030104980 Treating sexual desire disorders with flibanserin
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0773940B1 Process for synthesis of substituted sulphoxides
06/04/2003CN1110305C Naphthyl-substituted benzimidazole derivatives as anticoagulants
06/03/2003US6573379 Method for preparing halomethyl heterocyclic compounds
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003US6573218 Fused-benzene derivatives useful as herbicides
05/2003
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/29/2003US20030100592 Benzimidazole derivatives and salts and prodrugs thereof; treatment of cancers or viral infections
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100582 Benzimidazole compounds for regulating IgE
05/29/2003US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313719A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP0882705B1 Bis(aminocarbonylnaphthol) derivative
05/28/2003CN1109674C Imidazole deriv. and process for preparing same
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents
05/27/2003US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042184A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/22/2003WO2003041708A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003WO2003006670A3 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 154